PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.33
Ask: 3.34
Change: 0.00 (0.00%)
Spread: 0.01 (0.30%)
Open: 3.35
High: 3.35
Low: 3.26
Prev. Close: 3.35
MHPC Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partial Execution of the Over-allotment Option by

5 Jan 2011 07:00

RNS Number : 9138Y
MHP S.A.
05 January 2011
 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE RUSSIAN FEDERATION, UKRAINE, THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

05 January 2011

MHP S.A.

 

Announces Partial Execution of the Over-allotment Option by Joint Bookrunners of the Equity Offering

 

MHP S.A. ("MHP" or the "Company", LSE ticker: "MHPC"), one of the leading agro-industrial companies in Ukraine, focusing on the production of poultry and the cultivation of grain, announces today that during the over-allotment option period the Joint Bookrunners exercised in part their option to purchase 1,429,668 GDRs, representing approximately $23.6 million in gross proceeds. As a result, an aggregate of approximately 11.4 million GDRs were sold in connection with this offering. All GDRs were sold at $16.50 per GDR, resulting in a total offering size of approximately $188.6 million. The over-allotment option period has closed and no additional shares will be sold pursuant to the over-allotment option.

 

All of the GDRs in the offering, including the GDRs subject to the over-allotment option, were sold by WTI Trading Limited (the "Selling Shareholder"). The Company did not receive any proceeds from the sale of the shares in connection with this secondary offering. The Selling Shareholder, a limited liability company organised under the laws of Cyprus, is beneficially owned by Yuriy Kosiuk, the controlling beneficial shareholder and CEO of the Company.

 

In connection with the transaction, the Company and the Selling Shareholder have agreed to a 180 day lock-up arrangement.

 

Morgan Stanley and UBS Investment Bank acted as Joint Bookrunners for the Offering.

 

ENQUIRIES

MHP Investor Relations

Anastasiia Sobotiuk Kyiv: +38 044 207 99 58

Financial Dynamics

Ben Foster (London)

Marc Cohen (London)

Leonid Solovyev (Moscow)

 

 

London: +44 20 7831 3113

 

Moscow: +7 495 795 06 23

 

 

 

 

 

Important Notice

Morgan Stanley & Co International plc and UBS Limited, each of which is authorised and regulated in the UK by the Financial Services Authority, are acting exclusively for the Company and, in respect of only the sale of GDRs, the Selling Shareholder and no one else in connection with the Offering and will not regard any other person (whether or not a recipient of this announcement) as their respective clients and will not be responsible to anyone other than the Company and the Selling Shareholder for providing the protections afforded to clients of Morgan Stanley & Co. International plc and UBS Limited nor for giving advice in relation to the Offering, the contents of this announcement or any transaction or arrangement referred to herein.

 

The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in the United Kingdom or any other European Economic Area state, Australia, Canada, Japan, Ukraine, the Russian Federation, or the United States. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada, Japan, Ukraine or the Russian Federation or any other jurisdiction. There will be no public offer of the securities in the United States or elsewhere.

 

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom (subject to applicable laws), (ii) to investment professionals falling within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (iii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "Relevant Persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents. Persons distributing this document must satisfy themselves that it is lawful to do so.

 

In connection with the offering, Morgan Stanley & Co. International plc (the "Stabilizing Manager") (or persons acting on behalf of the Stabilizing Manager) may (but is under no obligation to) effect transactions in the GDRs with a view to supporting the market price of the GDRs at a level higher than that which might otherwise have prevailed in the open market. However, there is no assurance that the Stabilizing Manager (or persons acting on behalf of the Stabilizing Manager) will undertake stabilization action. Any stabilization action may begin on or after the date on which adequate public disclosure of the final price of the global depositary receipts is made and, if begun, may be ended at any time, but it must end no later than 30 days after the date of such adequate public disclosure of the final price of the GDRs. Any stabilization action must be conducted by the Stabilizing Manager (or person(s) acting on behalf of the Stabilizing Manager) in accordance with all applicable laws and rules. Save as required by law or regulation, neither the Stabilizing Manager nor any of its agents intends to disclose the extent of any stabilization transactions conducted in relation to the Offering.

 

This document is an advertisement and is not a prospectus for the purposes of EU Directive 2003/71/EC (the "Prospectus Directive") and Part VI of the Financial Services and Markets Act 2000 (the "FSMA"). In any EEA Member State that has implemented the Prospectus Directive this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.

 

In connection with the Offering, Morgan Stanley & Co. International plc or UBS Limited, or any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase GDRs and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such GDRs and other securities of the Company or related investments in connection with the Offering or otherwise. Accordingly, references to the GDRs being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by Morgan Stanley & Co. International plc or UBS Limited or any of their respective affiliates acting as investors for their own accounts. Morgan Stanley & Co. International plc and UBS Limited do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

 

The offer and the distribution of this press release and other information in connection with the offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

 

This announcement and information contained therein are for information purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. Information in this announcement cannot be relied upon as a guide to future performance. The price and value of securities may go up as well as down. Persons needing advice should contact a professional adviser.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGGMLDMGMZM
Date   Source Headline
2nd Jan 20153:45 pmRNSSecond Price Monitoring Extn
2nd Jan 20153:40 pmRNSPrice Monitoring Extension
30th Dec 20143:45 pmRNSSecond Price Monitoring Extn
30th Dec 20143:40 pmRNSPrice Monitoring Extension
29th Dec 20143:45 pmRNSSecond Price Monitoring Extn
29th Dec 20143:40 pmRNSPrice Monitoring Extension
17th Dec 20141:07 pmRNSChange in management
5th Dec 20149:22 amRNSDirector's Dealings
18th Nov 20147:00 amRNSFinancial Results for Q3 and 9M 2014
5th Nov 20147:00 amRNSDate Notification - Q3 and 9M 2014
14th Oct 20147:00 amRNSPre-close trading update for Q3 and 9M 2014
15th Sep 20143:40 pmRNSPrice Monitoring Extension
8th Sep 201410:24 amRNSDirector's Dealings: Data Correction
28th Aug 20147:00 amRNSFinancial Results for Q2 and H1 2014
18th Aug 20147:00 amRNSDate Notification - Q2 and H1 2014
5th Aug 20147:00 amRNSMHP - Shahtarska Nova breeding farm
15th Jul 20147:00 amRNSPre-close trading update for Q2 and H1 2014
3rd Jul 20149:41 amRNSChange in management
14th May 20147:10 amRNSDistribution of Dividends
14th May 20147:00 amRNSFinancial Results for Q1 2014
7th May 20147:00 amRNSDate Notification - Q1 2014
29th Apr 201410:21 amRNSResults of AGM
15th Apr 20147:00 amRNSPre-close trading update for Q1 2014
2nd Apr 20147:09 amRNSFinancial Results for Q4 and FY2013
27th Mar 20149:17 amRNSConvening Notice
24th Mar 20149:41 amRNSDate Notification - FY2013
4th Feb 20147:00 amRNSPre-close trading update for Q4/FY 2013
14th Nov 20137:00 amRNSQ3 and 9M Financial Results
5th Nov 20137:00 amRNSDate Notification Q3 and 9M 2013 Financial Results
15th Oct 20137:09 amRNSTrading Update for Q3 and 9M 2013
29th Aug 20137:03 amRNSUnaudited Financial Results for Q2 and H1 2013
19th Aug 20137:00 amRNSDate notification Q2 and H1 2013
18th Jul 201311:15 amRNSMHP - EU approval numbers for export
16th Jul 20137:00 amRNSPre-close trading update for Q2 and H1 2013
9th Jul 20139:16 amRNSAcquisition of grain growing facilities in Russia
23rd May 20131:13 pmRNSInvestor and Analyst Day 2013 Detailed Information
17th May 20137:00 amRNSFinancial results for Q1 2013
17th May 20137:00 amRNSDistribution of Dividends
13th May 20137:00 amRNSAcquisition of major holdings
30th Apr 20138:54 amRNSResults of General Meeting
26th Apr 20138:34 amRNSInvestor and Analyst Day 2013
24th Apr 20137:02 amRNSDate Notification Q1 2013
16th Apr 20137:00 amRNSPre-close trading update for Q1 2013
12th Apr 20137:14 amRNSConvening Notice (amended)
8th Apr 20138:04 amRNSResults of Tender Offer and Consent Solicitation
26th Mar 201312:17 pmRNSConvening Notice
22nd Mar 20131:57 pmRNSMHP S.A. Pricing Announcement
21st Mar 201312:14 pmRNSMHP RELEASES EARLY TENDER AND CONSENT RESULTS
7th Mar 20137:00 amRNSLaunch Announcement
5th Mar 20137:10 amRNSApproval of Dividend Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.